JO
FLGT icon

John Overdeck’s Fulgent Genetics FLGT Stock Holding History

John Overdeck’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,400
Closed -$2.35M – 3234
2021
Q4 		$2.35M Sell
23,400
-29,900
-56% -$2.63M 0.01% 1785
2021
Q3 		$4.79M Buy
53,300
+15,200
+40% +$1.38M 0.01% 1262
2021
Q2 		$3.51M Buy
38,100
+29,600
+348% +$2.36M 0.01% 1433
2021
Q1 		$821K Buy
+8,500
New +$877K ﹤0.01% 2492

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

John Overdeck's FLGT Position: Q2 2026 in Review

John Overdeck increased its Fulgent Genetics (FLGT) stake by 24% in Q2 2026, buying an estimated $1.34M and bringing the position to 400,986 shares worth $8.23M. The position accounts for 0.01% of the portfolio, ranked #1677.

John Overdeck first reported a position in FLGT in Q4 2019 and has held it in 13 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • John Overdeck held 400,986 shares of Fulgent Genetics worth $8.23M as of Q2 2026.
  • John Overdeck bought 78,797 Fulgent Genetics shares in Q2 2026, an estimated $1.34M.
  • Fulgent Genetics made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1677 holding.
  • John Overdeck first reported a position in Fulgent Genetics in Q4 2019 and has held it in 13 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.